{"id":"https://openalex.org/W2173390962","doi":"https://doi.org/10.1089/108729002321082438","title":"Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID Mice","display_name":"Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID Mice","publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2173390962","doi":"https://doi.org/10.1089/108729002321082438","mag":"2173390962","pmid":"https://pubmed.ncbi.nlm.nih.gov/12568310"},"language":"en","primary_location":{"id":"doi:10.1089/108729002321082438","doi":"https://doi.org/10.1089/108729002321082438","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108729002321082438","pdf_url":null,"source":{"id":"https://openalex.org/S92216883","display_name":"Antisense and Nucleic Acid Drug Development","issn_l":"1087-2906","issn":["1087-2906","2168-6599"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antisense and Nucleic Acid Drug Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009244604","display_name":"Volker Wacheck","orcid":"https://orcid.org/0000-0003-3962-5932","observed_orcids":["https://orcid.org/0000-0003-3962-5932"]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Volker Wacheck","raw_affiliation_strings":["Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037620517","display_name":"Clemens Krepler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Clemens Krepler","raw_affiliation_strings":["Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089908971","display_name":"Sabine Strommer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Sabine Strommer","raw_affiliation_strings":["Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002174658","display_name":"Elisabeth Heere\u2010Ress","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Elisabeth Heere-Ress","raw_affiliation_strings":["Department of Dermatology, Division of General Dermatology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Division of General Dermatology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010064115","display_name":"Robert E. Klem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Robert Klem","raw_affiliation_strings":["Genta, Inc., Berkeley Heights, NJ 07922. 4Prostate Centre, University of British Columbia, BC, V5Z"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genta, Inc., Berkeley Heights, NJ 07922. 4Prostate Centre, University of British Columbia, BC, V5Z","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112026684","display_name":"Hubert Pehamberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Hubert Pehamberger","raw_affiliation_strings":["Department of Dermatology, Division of General Dermatology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Division of General Dermatology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104781049","display_name":"Hans\u2010Georg Eichler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Hans-Georg Eichler","raw_affiliation_strings":["Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056905219","display_name":"Burkhard Jansen","orcid":"https://orcid.org/0000-0003-3425-444X","observed_orcids":["https://orcid.org/0000-0003-3425-444X"]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["AT","CA"],"is_corresponding":false,"raw_author_name":"Burkhard Jansen","raw_affiliation_strings":["Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria and Prostate Centre, University of British Columbia, BC, V5Z 3J5, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria and Prostate Centre, University of British Columbia, BC, V5Z 3J5, Vancouver, Canada","institution_ids":["https://openalex.org/I129774422","https://openalex.org/I141945490"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4757,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.8163522,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"12","issue":"6","first_page":"359","last_page":"367"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4284999966621399,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4284999966621399,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.34689998626708984,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.04619999974966049,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/g3139","display_name":"G3139","score":0.9769999980926514},{"id":"https://openalex.org/keywords/bcl-2-antisense-oligonucleotide","display_name":"Bcl-2 antisense oligonucleotide","score":0.968999981880188},{"id":"https://openalex.org/keywords/cpg-motifs","display_name":"CpG motifs","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cpg-methylation","display_name":"CpG methylation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/immunostimulation","display_name":"immunostimulation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6629999876022339},{"id":"https://openalex.org/keywords/tumor-cell-apoptosis","display_name":"tumor cell apoptosis","score":0.6029999852180481},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9869999885559082},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.8759999871253967},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6934102773666382},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6613041162490845},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.554199755191803},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.5488900542259216},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5070204734802246},{"id":"https://openalex.org/C140173407","wikidata":"https://www.wikidata.org/wiki/Q1138358","display_name":"CpG site","level":5,"score":0.4664784073829651},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.41970717906951904},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.418570876121521},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.35283172130584717},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2993355691432953},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27431681752204895},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1809641420841217},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.17510247230529785},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17297214269638062},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09026029706001282}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018899","descriptor_name":"CpG Islands","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019254","descriptor_name":"Genes, bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/108729002321082438","doi":"https://doi.org/10.1089/108729002321082438","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108729002321082438","pdf_url":null,"source":{"id":"https://openalex.org/S92216883","display_name":"Antisense and Nucleic Acid Drug Development","issn_l":"1087-2906","issn":["1087-2906","2168-6599"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antisense and Nucleic Acid Drug Development","raw_type":"journal-article"},{"id":"pmid:12568310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12568310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antisense & nucleic acid drug development","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321181","display_name":"Austrian Science Fund","ror":"https://ror.org/013tf3c58"},{"id":"https://openalex.org/F4320322325","display_name":"Oesterreichische Nationalbank","ror":"https://ror.org/00nkcmy90"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W135934099","https://openalex.org/W1787529017","https://openalex.org/W1984930006","https://openalex.org/W1999070120","https://openalex.org/W2000225595","https://openalex.org/W2015753524","https://openalex.org/W2020050900","https://openalex.org/W2031541967","https://openalex.org/W2042760441","https://openalex.org/W2059242249","https://openalex.org/W2061051459","https://openalex.org/W2092347182","https://openalex.org/W2113211717","https://openalex.org/W2124221273","https://openalex.org/W2136885844","https://openalex.org/W2149484379","https://openalex.org/W2173547083","https://openalex.org/W2193208812","https://openalex.org/W2412157395"],"related_works":["https://openalex.org/W2091249894","https://openalex.org/W2095985837","https://openalex.org/W2052500856","https://openalex.org/W2133933047","https://openalex.org/W2338130374","https://openalex.org/W2529687234","https://openalex.org/W2151650355","https://openalex.org/W2005506063","https://openalex.org/W2027891144","https://openalex.org/W2557961665"],"abstract_inverted_index":{"The":[0],"Bcl-2":[1,117,190],"antisense":[2,191],"oligonucleotide":[3],"(AS-ODN)":[4],"G3139":[5,16,55,79,94,127,138,168,182,200],"chemosensitizes":[6],"human":[7,73],"malignancies":[8],"by":[9,44,84,101,126],"downregulating":[10],"the":[11,30,49,66,107,178],"antiapoptotic":[12],"protein":[13],"Bcl-2.":[14],"Because":[15],"contains":[17],"two":[18,67],"potential":[19,53],"immunostimulatory":[20,52],"CpG":[21,39,68],"motifs,":[22],"we":[23,111],"asked":[24],"if":[25],"immune":[26,42,197],"stimulation":[27,43],"contributes":[28],"to":[29,106,152,187],"antitumor":[31,50,179],"activity":[32],"observed":[33],"previously.":[34],"5'-Methylation":[35],"of":[36,54,63,116,181,196],"cytosines":[37,64],"in":[38,65,121,143,183],"motifs":[40,69],"abrogates":[41],"oligonucleotides.":[45],"We,":[46],"therefore,":[47],"studied":[48],"and":[51,95,119,128,146,161,201,210],"vs.":[56],"an":[57],"identical":[58],"oligonucleotide,":[59],"except":[60],"for":[61],"methylation":[62],"(G4232).":[70],"In":[71],"a":[72,113,140,189],"melanoma":[74],"SCID":[75],"mouse":[76],"xenotransplantation":[77],"model,":[78],"or":[80,88,158],"G4232":[81,96,129,157,205],"was":[82],"administered":[83],"continuous":[85],"subcutaneous":[86],"(s.c.)":[87],"bolus":[89],"intraperitoneal":[90],"(i.p.)":[91],"infusion.":[92],"Both":[93],"significantly":[97],"reduced":[98],"tumor":[99,122,208],"growth":[100],"about":[102],"one":[103],"third":[104],"relative":[105,151],"saline-treated":[108],"group.":[109],"Furthermore,":[110],"noted":[112],"similar":[114,207],"downregulation":[115],"expression":[118],"increase":[120,142],"cell":[123],"apoptosis":[124,211],"caused":[125,206],"compared":[130],"with":[131,137,155],"saline":[132],"controls.":[133],"However,":[134,172],"mice":[135,153],"treated":[136,154],"had":[139],"pronounced":[141],"spleen":[144],"weight":[145],"interleukin-12":[147],"(IL-12)":[148],"plasma":[149,164],"levels":[150,165],"either":[156],"saline.":[159],"Splenomegaly":[160],"elevated":[162],"IL-12":[163],"suggest":[166],"that":[167,177,193],"can":[169],"be":[170,188],"immunostimulatory.":[171],"there":[173],"is":[174,194],"clear":[175],"evidence":[176],"effect":[180,192],"this":[184],"model":[185],"appears":[186],"independent":[195],"stimulation,":[198],"as":[199],"its":[202],"immune-silent":[203],"counterpart":[204],"suppression":[209],"induction.":[212]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}